Treating Schizophrenia: New Strategies

By Williamson, John S; Wyandt, Christy M | Drug Topics, November 6, 2000 | Go to article overview

Treating Schizophrenia: New Strategies

Williamson, John S; Wyandt, Christy M, Drug Topics

Schizophrenia is a complex disease of uncertain etiology, afflicting approximately 1% to 2% of all populations worldwide, including three million Americans. It causes untold suffering for patients as well as their families. In the United States, direct and indirect costs of schizophrenia are more than $30 billion annually, and this figure does not include the costs associated with homelessness (an estimated 33% to 50% of homeless Americans are schizophrenic).

Schizophrenia is a psychotic disorder that is poorly understood and often mistaken by the public as a more debilitating dementia. Many people erroneously believe that schizophrenia involves a divided psyche or multiple personalities and that schizophrenics are prone to violence. The fact is that schizophrenics do not suffer from multiple personalities, and although their behavior may sometimes become violent, they are far more likely to withdraw from society. Although there is no known cure for schizophrenia, many of the newer antipsychotic (AP) agents have allowed many patients to live relatively normal lives.

Because schizophrenia usually appears early in life (most commonly between the ages of 16 and 30) and can often be chronic, the costs of the disorder are substantial.

With the varying chemical therapies and side effects associated with the treatment of schizophrenia, the pharmacist can play an important role in overall successful treatment of these patients. For example, the pharmacist can help the patient and family better understand the disease, its early signs and symptoms (Table 1), and, most important, the side effects associated with drug therapy.

Epidemiology and etiology

The prevalence of schizophrenia varies, but the results of most studies suggest a rate of slightly less than 2% of the population. The disorder appears to be uniformly distributed worldwide, although pockets of high or low prevalence may exist.

The etiology of schizophrenia is not fully understood; however, it appears that approximately 10% of the patients with schizophrenia will have a parent who suffers from the illness. This is believed to indicate a genetic basis rather than an environmental one. Nevertheless, stress can precipitate the illness and is well implicated in people who are genetically predisposed to the disease (Table 2).

If there is no family history of schizophrenia, the chances of being diagnosed with the disease are only 1 in 100. If the disease exists within the immediate family, the chances increase to approximately 1 in 10. If both parents are schizophrenic, there is a 1-in-4 chance of being diagnosed with the disease. If a person's parents or siblings have schizophrenia, the chances of the person's children acquiring the illness are only slightly increased (3 in 100).

Scientists have identified a number of genes that may be linked to schizophrenia. This suggests that different kinds of biochemical problems may lead to schizophrenia in different people (just as there are different kinds of arthritis). Nevertheless, many factors besides genetics are also involved. Research is currently under way to identify these factors and learn how they affect one's chances of developing the illness. Although many studies have looked for a correlation, there is no evidence to suggest that schizophrenia is caused by bad parenting, trauma, abuse, or personal weakness.

Drug treatment allows many patients suffering from schizophrenia to be symptom free, but approximately one-- fifth to one-third of schizophrenic patients do not respond adequately to drug treatment. The proportion of patients with this "drug-- resistant" schizophrenia has remained consistent over time, and the treatment of these patients is a persistent public health problem. Unfortunately, treatment-resistant patients are often highly symptomatic and generally require extensive periods of hospital care.

The dysfunction of several neurotransmitter systems like dopamine (DA), 5-hydroxytryptamine (5-HT; serotonin), and glutamate (GLU) are thought to play a part in schizophrenia. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • A full archive of books and articles related to this one
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Cite this article

Cited article

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)


1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25,

Cited article

Treating Schizophrenia: New Strategies


Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Citations are available only to our active members.
    Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25,

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

    Already a member? Log in now.